These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38629923)

  • 1. JN.1: ongoing considerations of the shifting landscape of SARS-CoV-2 variants.
    Basu S; Kayal T; Patro PP; Patnaik A
    Future Microbiol; 2024; 19(7):559-562. PubMed ID: 38629923
    [No Abstract]   [Full Text] [Related]  

  • 2. JN.1 variant in enduring COVID-19 pandemic: is it a variety of interest (VoI) or variety of concern (VoC)?
    Kamble P; Daulatabad V; Singhal A; Ahmed ZS; Choubey A; Bhargava S; John NA
    Horm Mol Biol Clin Investig; 2024 Jun; 45(2):49-53. PubMed ID: 38622986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the emergence of SARS-CoV-2 JN.1 sub-variant: Insights from the first cases at Charles Nicolle Hospital, Tunisia.
    Hamzaoui Z; Ferjani S; Kanzari L; Ben Ali R; Charaa L; Landolsi I; Medini I; Chammam S; Abid S; Ferjani A; Kebaier D; Fakhfakh A; Bouslah Z; Ben Sassi M; Trabelsi S; Boutiba-Ben Boubaker I
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):165-171. PubMed ID: 38717854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1.
    Sohail MS; Ahmed SF; Quadeer AA; McKay MR
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion.
    Li P; Liu Y; Faraone JN; Hsu CC; Chamblee M; Zheng Y-M; Carlin C; Bednash JS; Horowitz JC; Mallampalli RK; Saif LJ; Oltz EM; Jones D; Li J; Gumina RJ; Liu S-L
    mBio; 2024 May; 15(5):e0075124. PubMed ID: 38591890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and clinical manifestations of patients, including organ transplant patients, during the surge of JN.1: Insights from Saudi Arabia.
    Obeid DA; Al-Qahtani AA; Almaghrabi RS; Alahideb BM; Alharbi LA; AlAbdulkareem MA; Almadi TM; Alsanea MS; Althawadi SI; Altamimi SA; Alhamlan FS
    J Infect Public Health; 2024 Jul; 17(7):102452. PubMed ID: 38820895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omicron variants of SARS-CoV-2: Epidemiological and clinical insights from a tertiary care center in Saudi Arabia.
    Dubaie B; Aldayel A; Alwethinani S; Alhuthil R; Alhamlan F; Alghamdi S; Alsuhaibani M; Aljumaah S; AlYabes O; AlBanyan E; Al-Hajjar S
    J Infect Public Health; 2024 Jun; 17(6):961-966. PubMed ID: 38608457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variability of the SARS-CoV-2 JN.1 lineage.
    Scarpa F; Ciccozzi M
    Pathog Glob Health; 2024 May; 118(3):277-279. PubMed ID: 38616495
    [No Abstract]   [Full Text] [Related]  

  • 12. Another variant another history: description of the SARS-CoV-2 KP.2 (JN.1.11.1.2) mutations.
    Branda F; Ciccozzi A; Romano C; Ciccozzi M; Scarpa F
    Infect Dis (Lond); 2024 Jul; 56(7):581-585. PubMed ID: 38809158
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023.
    Jeworowski LM; Mühlemann B; Walper F; Schmidt ML; Jansen J; Krumbholz A; Simon-Lorière E; Jones TC; Corman VM; Drosten C
    Euro Surveill; 2024 Jan; 29(2):. PubMed ID: 38214083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.
    Rodríguez-Maldonado AP; Vázquez-Pérez JA; Cedro-Tanda A; Taboada B; Boukadida C; Wong-Arámbula C; Nuñez-García TE; Cruz-Ortiz N; Barrera-Badillo G; Hernández-Rivas L; López-Martínez I; Mendoza-Vargas A; Reyes-Grajeda JP; Alcaraz N; Peñaloza-Figueroa F; Gonzalez-Barrera D; Rangel-DeLeon D; Herrera-Montalvo LA; Mejía-Nepomuceno F; Hernández-Terán A; Mújica-Sánchez M; Becerril-Vargas E; Martínez-Orozco JA; Pérez-Padilla R; Salas-Hernández J; Sanchez-Flores A; Isa P; Matías-Florentino M; Ávila-Ríos S; Muñoz-Medina JE; Grajales-Muñiz C; Salas-Lais AG; Santos Coy-Arechavaleta A; Hidalgo-Miranda A; Arias CF; Ramírez-González JE
    Arch Virol; 2021 Nov; 166(11):3173-3177. PubMed ID: 34448936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Evolution of SARS-CoV-2 in West Sumatra: Analyzing S Gene Mutations Across Variants and Their Impact on Public Health and Vaccine Strategies.
    Linosefa L; Hasmiwati H; Jamsari J; Putra AE
    Pak J Biol Sci; 2024 Mar; 27(4):182-189. PubMed ID: 38812109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.
    Molina-Mora JA; Cordero-Laurent E; Godínez A; Calderón-Osorno M; Brenes H; Soto-Garita C; Pérez-Corrales C; ; Drexler JF; Moreira-Soto A; Corrales-Aguilar E; Duarte-Martínez F
    Infect Genet Evol; 2021 Aug; 92():104872. PubMed ID: 33905892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.
    Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H
    Front Public Health; 2022; 10():915363. PubMed ID: 35859775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021.
    Lai A; Bergna A; Menzo S; Zehender G; Caucci S; Ghisetti V; Rizzo F; Maggi F; Cerutti F; Giurato G; Weisz A; Turchi C; Bruzzone B; Ceccherini Silberstein F; Clementi N; Callegaro A; Sagradi F; Francisci D; Venanzi Rullo E; Vicenti I; Clementi M; Galli M;
    Virol J; 2021 Aug; 18(1):168. PubMed ID: 34391446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.